|Bid||0.0000 x 0|
|Ask||0.0000 x 0|
|Day's Range||1.5700 - 1.5700|
|52 Week Range||1.1000 - 11.0000|
|Beta (3Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Earnings Date||Apr 5, 2019 - Apr 8, 2019|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||7.25|
NEW YORK , June 5, 2019 /PRNewswire/ -- OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today announced the lists of downgrades from its respective ...
In the latest trading session, Nexeon MedSystems, Inc. (NXNN) closed at $3.50, marking no change from the previous day.
Nexeon MedSystems Inc (”Nexeon”) (NXNN), a neurostimulation medical device company, announced today financial results for the third quarter of 2018. The Puerto Rico Science, Technology, and Research Trust has committed $100,000 in matching funds to support the first phase of the project. Consolidated revenues for the third quarter of 2018 were $1.98 million, a 0.4% decrease from pro forma consolidated revenues of $1.99 million for the third quarter of 2017.
Nexeon MedSystems, Inc (”Nexeon”) (NXNN), a neurostimulation medical device company, announced that it has received grant matching funds from the Puerto Rico Science, Technology, and Research Trust (“Trust”). The National Institute of Neurological Disorders and Stroke (NINDS) of the National Institutes of Health (NIH) recently awarded a $830,000 grant to Nexeon’s wholly-owned subsidiary, Nexeon MedSystems Puerto Rico Operations Corporation (“NMPROC”, “Nexeon PR”, or “the Company”).